Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Trump Administration, AstraZeneca Reach Deal to Cut Drug Prices and Expand U.S. Investment

Summary by MyChesCo
WASHINGTON, D.C. — President Donald J. Trump on Friday announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering prescription drug costs and strengthening U.S. manufacturing, part of a broader effort to align American drug prices with those paid in other developed nations. The agreement, the second of its kind under the administration’s “most-favored-nation” initiative, will give every state Medicaid program access to A…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

5 Articles

In an effort to ease the financial burden on U.S. patients and encourage investment in the domestic pharmaceutical industry, the Trump administration has reached a landmark agreement with AstraZeneca.

U.S. President Donald Trump signed an agreement with the British-Swedish pharmaceutical company AstraZeneca, under which the company will sell certain drugs at a discount through the government's Medicaid healthcare program in exchange for tariff breaks. The White House previously reached a similar agreement with Pfizer.

·Poland
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

ORF.at News broke the news in Vienna, Austria on Saturday, October 11, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal